Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at the 2025 American Association of Nurse Practitioners (AANP) National Conference SAN DIEGO, June 20, 2025...
Hence then, the article about neurocrine biosciences presents new data showing significant patient reported improvements in health related quality of life with ingrezza valbenazine capsules in older adults with tardive dyskinesia was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia )
Also on site :
- Watch the N.H. Liquor & Wine Outlet video that’s lowkey going viral
- Nicotine pouch tax increase aims to protect kids, but producers and lawmakers fear impact on smokers trying to quit
- Authorities Searching for Suspect After Woman Stabbed to Death in Hillsborough